Revolution Medicines, Inc. beat EPS estimates 0% of the time across 3 reported quarters (0 beats, 3 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-1.93 | $-2.34 | -21.2% | Miss |
| Q12026 FY2026 | $-1.83 | $-2.29 | -25.1% | Miss |
| Q42025 FY2025 | $-1.56 | $-1.86 | -19.2% | Miss |
Back to RVMD overview · RVMD holders · RVMD KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.